Sézary Syndrome
📧 Sign up to get email alerts when something new happens for Sézary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]
Phase 1 clinical trial evaluating the combination of duvelisib and nivolumab for stage IIb–IVB mycosis fungoides and Sézary syndrome; trial …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients [Phase 2]
A Phase 2 trial update describes dosing of Brentuximab Vedotin for patients with Mycosis fungoides and Sézary syndrome, with lymphomatoid pa…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab in combination with gemcitabine in adults with advanced mycosis fungoides or Sézary s…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)
A clinical trial update investigating lymphocyte phenotype in autosomal recessive congenital ichthyoses due to NIPAL4 mutation (NIPAL4-nEDD)…
-
FDA approval · 2026-02-19FDA Approved: POTELIGEO — Supplemental Application (Kyowa Kirin, Inc.)
The FDA approved a supplemental application for POTELIGEO (mogamulizumab-kpkc) by Kyowa Kirin, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome [Phase 1]
A Phase 1 clinical trial evaluating Tulmimetostat (DZR123) in patients with mycosis fungoides and Sézary syndrome; the study is currently ac…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphoma, …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Extracorporeal Photopheresis in Sezary Syndrome
This clinical trial update shows that recruitment is ongoing for a study evaluating extracorporeal photopheresis in Sézary syndrome. No effi…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This clinical trial update indicates ongoing recruitment for a University of Pittsburgh study collecting blood, urine, and tissue samples fr…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
A real-world study reports on the use of mogamulizumab for treating cutaneous T-cell lymphoma and its subtypes.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
A clinical trial update notes ongoing recruitment for systemic therapies in the treatment of cutaneous T-cell lymphoma, including mycosis fu…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Tissue Repository: CTCL Collection Protocol
This clinical trial update describes a tissue repository protocol for collecting samples related to cutaneous T-cell lymphoma (CTCL) and rel…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This Stanford University clinical trial aims to identify prognostic factors in Mycosis fungoides and Sézary syndrome and is currently recrui…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of extracorporeal photopheresis and mogamulizumab for erythrodermic cutaneous T-cell lymphoma, curr…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) [EARLY_Phase 1]
A first-in-human Phase 1 dose-escalation study of DT-7012, a CCR8-targeting monoclonal antibody from Domain Therapeutics, in relapsed or ref…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
A clinical trial update on mogamulizumab (Poteligeo) assessing safety and efficacy through use-result surveillance in patients with mycosis …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy [Phase 4]
Phase 4 update evaluating KW-0761 (mogamulizumab) for Mycosis fungoides or Sézary syndrome in Chinese patients who have previously received …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
A US-based prospective study examining mogamulizumab-associated rash in patients with mycosis fungoides or Sézary syndrome who are treated w…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ritlecitinib in CTCL [Phase 2]
A Phase 2 trial of ritlecitinib for cutaneous T-cell lymphoma was terminated.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome [Phase 2]
Clinical trial evaluating mogamulizumab with low-dose total skin electron beam therapy in Sézary syndrome and mycosis fungoides, Phase 2, cu…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma [Phase 1]
A Phase 1 trial evaluating reduced-intensity conditioning before a partially matched donor stem cell transplant for advanced cutaneous T-cel…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
This clinical trial is recruiting to evaluate predictive and prognostic biomarkers in patients with Mycosis fungoides and Sézary syndrome.
-
FDA approval · 2025-01-21FDA Approved: POTELIGEO — Supplemental Application (Kyowa Kirin, Inc.)
FDA approved a supplemental application for POTELIGEO (mogamulizumab-kpkc) submitted by Kyowa Kirin, Inc., as part of the drug's regulatory …
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Prospective multicenter study evaluating flow cytometry detection of the KIR3DL2 marker for diagnosing Sézary syndrome, assessing therapeuti…